Skip to Main Content

Paper Details

The clinical utility and costs of whole-genome sequencing to detect cancer susceptibility variants-a multi-site prospective cohort study.
Genome Med
1
2023
cancer, cancer predisposition genes, cancer(s), cancers, hereditary cancer syndrome, participant, participants, patients
Author NameAffiliation
Nicholas PachterKing Edward Memorial Hospital
Nicholas PachterUniversity of Western Australia
Sharron TownshendKing Edward Memorial Hospital
Nicola K PoplawskiAdelaide Medical School, University of Adelaide
Nicola K PoplawskiAdelaide Medical School, University of Adelaide
Nicola K PoplawskiRoyal Adelaide Hospital
Nicola K PoplawskiRoyal Adelaide Hospital
Amanda B SpurdleQIMR Berghofer Medical Research Institute
Amanda B SpurdleUniversity of Queensland
Amanda B SpurdleQIMR Berghofer Medical Research Institute
Amanda B SpurdleUniversity of Queensland
Nicola WaddellQIMR Berghofer Medical Research Institute
Nicola WaddellUniversity of Queensland
Nicola WaddellQIMR Berghofer Medical Research Institute
Nicola WaddellUniversity of Queensland
Robyn L WardUniversity of Queensland
Robyn L WardUniversity of Sydney
Robyn L WardUniversity of Queensland
Robyn L WardUniversity of Sydney
  • 1 - 19

Datasets

Release 1.2